Details of Host Protein-DME Interaction (HOSPPI)
| General Information of Drug-Metabolizing Enzyme (DME ID: DME0501) | |||||
|---|---|---|---|---|---|
| DME Name | Soluble aminopeptidase P (sAmp), Homo sapiens | DME Info | |||
| UniProt ID | |||||
| EC Number | EC: 3.4.11.9 (Click to Show/Hide the Complete EC Tree) | ||||
| Lineage | Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage) | ||||
| Interactome | |||||
| Disease Specific Interactions between Host Protein and DME (HOSPPI) | |||||
|---|---|---|---|---|---|
| ICD Disease Classification 05 Endocrine/nutritional/metabolic diseases | |||||
| ICD-11: 5A61 Pituitary gland hypofunction | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
| DNA methylation | |||||
| DNA methyltransferase (DNMT) | Chordoma | Significant hypomethylation | |||
| Interaction Name | DNMT-sAmp interaction | ||||
| The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypomethylation p-value: 1.38E-03; delta-beta: -4.74E-01 | ||||
| Description | DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the sAmp gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Soluble aminopeptidase P. As a result, the interaction between DNMT and sAmp can significantly affect the drug-metabolizing process of Soluble aminopeptidase P. | ||||
|
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
| Violin Diagram of DME Disease-specific Methylation Level |
|
Click to View the Clearer Original Diagram | |||
| ICD Disease Classification 02 Neoplasms | |||||
| ICD-11: 2A01 Meningeal tumour | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
| DNA methylation | |||||
| DNA methyltransferase (DNMT) | Meningioma | Significant hypomethylation | |||
| Interaction Name | DNMT-sAmp interaction | ||||
| The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypomethylation p-value: 2.14E-93; delta-beta: -5.10E-01 | ||||
| Description | DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the sAmp gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Soluble aminopeptidase P. As a result, the interaction between DNMT and sAmp can significantly affect the drug-metabolizing process of Soluble aminopeptidase P. | ||||
|
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
| Violin Diagram of DME Disease-specific Methylation Level |
|
Click to View the Clearer Original Diagram | |||
| ICD-11: 2C73 Ovarian cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
| DNA methylation | |||||
| DNA methyltransferase (DNMT) | Ovarian cancer | Significant hypermethylation | |||
| Interaction Name | DNMT-sAmp interaction | ||||
| The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypermethylation p-value: 7.24E-04; delta-beta: 3.34E-01 | ||||
| Description | DNA methyltransferase (DNMT) is reported to significantly hyper-methylate the sAmp gene, which leads to a significantly decreased expression of the drug-metabolizing enzyme Soluble aminopeptidase P. As a result, the interaction between DNMT and sAmp can significantly affect the drug-metabolizing process of Soluble aminopeptidase P. | ||||
|
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
| Violin Diagram of DME Disease-specific Methylation Level |
|
Click to View the Clearer Original Diagram | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.